Detection and clearance of prostate cells subsequent to ultrasound- guided needle biopsy as determined by multiplex nested reverse transcription polymerase chain reaction assay

Urology

Volumn 52, Issue 2, 1998, Pages 261-267

  Price, Douglas K ^a   Clontz, Diana R ^b   Woodard III, Warden L ^b   Kaufman, Jay S ^b   Daniels, Jane M ^b   Stolzenberg, Suzanne J ^b   Teigland, Chris M ^b  

^a CAROLINAS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CONTROLLED STUDY; FINGER; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; RECTUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSRECTAL ULTRASONOGRAPHY; TUMOR CELL;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 0032146124     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00148-4     Document Type: Article

References (21)

1. Oesterling J.E., Rice D.C., Glenski W.J., et al. Effect of cystoscopy, prostate biopsy, and transurethral resection of prostate on serum prostate-specific antigen concentration. Urology. 42:1993;276-282.
2. Paget S. The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev. 8:1889;98-101.
3. Weiss L., Orr F.W., Honn K.V. Interactions of cancer cells with the microvasculature during metastasis. FASEB J. 2:1988;12-21.
4. Ghossein R.A., Rosai J. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer. 78:1996;10-16.
5. Pelkey T.J., Frierson H.F. Jr, Bruns D.E. Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem. 42:1996;1369-1381.
6. Katz A.E., Olsson C.A., Raffo A.J., et al. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology. 43:1994;765-775.
7. Israeli R.S., Miller W. Jr, Su S.L., et al. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays . Cancer Res. 54:1994;6306-6310.
8. Loric S., Dumas F., Eschwege P., et al. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen. Clin Chem. 41:1995;1698-1704.
9. Sokoloff M.H., Tso C.L., Kaboo R., et al. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging a clinicopathological molecular analysis of 121 patients . J Urol. 156:1996;1560-1566.
10. Wood D.P. Jr, Banks E.R., Humphreys S., et al. Identification of bone marrow micrometastases in patients with prostate cancer. Cancer. 74:1994;2533-2540.
11. Price D., Woodard W., Teigland C. Simultaneous detection of circulating prostate specific antigen (PSA)-expressing and prostate specific membrane antigen (PSM)-expressing cells by a multiplex reverse transcriptase polymerase chain reaction (RT-PCR) assay. Urol Oncol. 1:1995;226-233.
12. Sambrook J., Fritsch E., Maniatis T. Molecular Cloning A Laboratory Manual . 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
13. Moreno J.G., O'Hara S.M., Long J.P., et al. Transrectal ultrasound-guided biopsy causes hematogenous dissemination of prostate cells as determined by RT-PCR. Urology. 49:1997;515-520.
14. Cama C., Olsson C.A., Buttyan R., et al. Molecular staging of prostate cancer III, Effects of cystoscopy and needle biopsy on the enhanced reverse transcriptase polymerase chain reaction assay . J Urol. 157:1997;1748-1751.
15. Yuan J.J., Coplen D.E., Petros J.A., et al. Effects of rectal examination, prostatic massage, ultrasonography, and needle biopsy on serum prostate specific antigen levels. J Urol. 147:(3 Pt 2):1992;810-814.
16. Chybowski F.M., Bergstralh E.J., Oesterling J.E. The effect of digital rectal examination on the serum prostate specific antigen concentration results of a randomized study . J Urol. 148:1992;83-86.
17. Moreno J.G., Croce C.M., Fischer R., et al. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res. 52:1992;6110-6112.
18. Katz A.E., de Vries G.M., Begg M.D., et al. Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer. 75:1995;1642-1648.
19. Seiden M.V., Kantoff P.W., Krithivas K., et al. Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol. 12:1994;2634-2639.
20. Ghossein R.A., Scher H.I., Gerald W.L., et al. Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma clinical implications . J Clin Oncol. 13:1995;1195-1200.
21. Cama C., Olsson C.A., Raffo A.J., et al. Molecular staging of prostate cancer II A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen . J Urol. 153:1995;1373-1378.